SA Insights: Discover BioCina
31 January 2023
Registrations are now open for MTPConnect’s SA Insights Series for February.
Stephanie Morris, Director of Innovation & Translation, Adelaide Intermediary Program will be joined by CEO of BioCina, Ian Wisenberg, and Vice President and General Manager Michael Tsaconas for a fire-side chat.
BioCina is a CDMO with the only FDA-approved microbial drug substance facility of its kind in Australia, providing high-quality, cost-effective process development and manufacturing solutions to biopharmas worldwide. The site, based in Thebarton, was approved by the FDA for commercial manufacturing in 2020.
During this chat you will learn about the history of this iconic manufacturing site and SA’s Contract Development Manufacturing Organisation (CDMO) capability.
Discover what can be produced, market reach, and lessons learnt in scaling the business model.
Ian will share insights into the importance of relationship building and the opportunities and challenges of being part of a global organisation.
Ian’s philosophy “never do tomorrow what you can do today,” has fueled his entrepreneurial successes – Let’s discover what Ian and BioCina have planned for tomorrow and beyond.
This event will be followed by an opportunity to network over drinks and nibbles.
Who should attend?
Researchers, C-suite professionals in the Health and Medical Innovation sector, investors, and entrepreneurs, clinicians, Medtech Pharma, BioTech and Digital health industry professionals, commercialisation executives, and members of the Adelaide ecosystem.
Bring a Plus 1
If you register for TWO today, meet-up at the SA Insights Series event and you are in the running to WIN a prize. Bring a colleague or invite a person you have been trying to connect with.